McMaster University's study reveals a shocking 80% higher dementia risk post-stroke, emphasizing the urgent need for enhanced stroke prevention and comprehensive survivor care.
Revolutionizing Alzheimer's diagnosis, a non-invasive blood test matches lumbar puncture accuracy. ALZpath p-tau217 test categorizes patients, promising early intervention and broader accessibility.
Ireland secures access to Libmeldy, the world's priciest drug for Metachromatic Leukodystrophy, benefiting children. Beneluxa initiative's negotiations with Orchard Therapeutics led to an undisclosed lower cost.